Article Details

CARISMA Therapeutics Completes Series B Funding for $47 Million to Advance Development of ...

Retrieved on: 2021-01-07 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

CARISMA Therapeutics Completes Series B Funding for $47 Million to Advance Development of .... View article details on hiswai:

Excerpt

... from existing investors including AbbVie Ventures, HealthCap, Wellington Partners, IP Group, TPG Biotech, Agent Capital, and MRL Ventures Fund.

Article found on: www.oaoa.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up